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Abstract
Background: In deciding where to undergo coronary-artery bypass grafting, the length of surgical
wait lists is often the only information available to cardiologists and their patients. Our objective
was to compare the cumulative incidence for death on the wait list according to the length of wait
lists at the time of registration for the operation.
Methods: The study cohort included 8966 patients who registered to undergo isolated coronary-
artery bypass grafting (82.4% men; 71.9% semi-urgent; 22.4% non-urgent). The patients were
categorized according to wait-list clearance time at registration: either "1 month or less" or "more
than 1 month". Cumulative incidence for wait-list death was compared between the groups, and
the significance of difference was tested by means of regression models.
Results: Urgent patients never registered on a wait list with a clearance time of more than 1
month. Semi-urgent patients registered on shorter wait lists more often than non-urgent patients
(79.1% vs. 44.7%). In semi-urgent and non-urgent patients, the observed proportion of wait-list
deaths by 52 weeks was lower in category "1 month or less" than in category "more than 1 month"
(0.8% [49 deaths] vs. 1.6% [39 deaths], P < 0.005). After adjustment, the odds of death before
surgery were 64% higher in patients on longer lists, odds ratio [OR] = 1.64 (95% confidence interval
[CI] 1.02–2.63). The observed death rate was higher in category "more than 1 month" than in
category "1 month or less", 0.79 (95%CI 0.54–1.04) vs. 0.58 (95% CI 0.42–0.74) per 1000 patient-
weeks, the adjusted OR = 1.60 (95%CI 1.01–2.53). Longer wait times (log-rank test = 266.4, P <
0.001) and higher death rates contributed to a higher cumulative incidence for death on the wait
list with a clearance time of more than 1 month.
Conclusion: Long wait lists for coronary-artery bypass grafting are associated with increased
probability that a patient dies before surgery. Physicians who advise patients where to undergo
cardiac revascularization should consider the risk of pre-surgical death that is associated with the
length of a surgical wait list.
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Background
In patients with coronary artery disease (CAD) who are to
undergo coronary artery bypass grafting (CABG), delaying
that operation may lead to the deterioration of the
patient's condition, a poor clinical outcome, and an
increased risk of death [1-3]. A patient who presents with
the symptoms of CAD is usually referred to a cardiologist,
who evaluates the results of coronary angiography and
recommends treatment. If coronary angioplasty is not
indicated, that patient is referred to a cardiac surgeon,
who assesses the need for and suitability of CABG surgery.
Patients who require immediate care are admitted to a
hospital cardiac ward directly from the catheterization
laboratory. Elective patients are scheduled for outpatient
consultation with the cardiac surgeon. After the consulta-
tion in which a CABG is deemed necessary, surgeons reg-
ister patients on their wait lists. The detailed pathway to
surgical revascularization has been described elsewhere
[4]. Surgical wait lists hold patient names until surgery can
be scheduled. Patients are removed from the wait list
without having undergone surgery if they die, refuse the
operation, accept surgery from another surgeon, move out
of the province, or experience a health-related decline that
contraindicates surgery.
It has been argued that cardiologists and their patients
should assess the likely extent of treatment delay and asso-
ciated risks when they choose a cardiac surgeon [5]. In
deciding where to undergo treatment, wait-list size is
often the only information available to cardiologists and
their patients because the length of the wait list for surgery
is a common correlate of the expected wait for hospital
admission. Indeed, all patients on a wait list must be
treated before a patient who has just registered for surgery
can be scheduled for treatment. We previously performed
an empirical analysis of a population-based registry and
found that the length of queue at registration affected the
time to elective surgery [4]. Surprisingly, few studies have
correlated the health effects of the pre-surgical wait with
wait-list size at the time of registration for an elective
CABG. The common concern is whether the decision to
refer a patient to a specific cardiac surgeon can be made
without considering the length of the current wait list.
We performed a prospective study of all patients who reg-
istered to undergo isolated CABG surgery from 1991
through 2000 in British Columbia, Canada. We estimated
the time-dependent probability for death during or before
a certain wait-list week in a patient who could be removed
from a surgical waiting list for surgery, death, or other rea-
sons. The objective of this study was to compare the
cumulative incidence of wait-list death between two
groups of patients classified according to the length of
wait lists at the time of their registration for CABG and to
test for significant differences in the risk of death resulting
from registration on a longer wait list.
Patients and methods
Data sources
The data were taken from the British Columbia Cardiac
Registries [6]. That prospectively collected database con-
tains information about registration, procedure, or with-
drawal dates, and about disease severity and other risk
factors for all patients registered for surgical coronary
revascularization in 1 of the 4 tertiary-care hospitals that
provide cardiac care to adult residents of the Canadian
province of British Columbia since 1991 [4]. To identify
the date and underlying cause of death of registered
patients who died before they could undergo CABG, we
linked the registry to British Columbia Linked Health
Database Deaths File by patients' Provincial Health
Number [7]. Underlying causes of death were coded
according to the International Classification of Diseases,
9th revision (ICD-9). To identify coexisting medical con-
ditions in the study cohort we linked the registry to the BC
Linked Health Database Hospital Separations File [8] for
the period of 1990 through 2001 and retrieved diagnoses
reported in discharge abstracts within 1 year before regis-
tration for CABG [9]. The University of British Columbia
Ethics Board approved the protocol for this study.
Patients
Between January 1991 and December 2000, 9366 records
of patients who registered for isolated CABG were added
to the registry. We excluded 30 records of patients who
were coded as emergency cases, 99 who had the same date
for registration and removal, 4 whose operating room
report was missing, and 267 who underwent surgery
within one to three days after having been registered on a
wait list. The remaining 8966 records had either the sur-
gery date or the date and reason of removal from the wait
list without surgery. Because patients whose angiographic
findings indicated the need for immediate surgery were
not added to a wait list, they were not included in the
analysis of wait-list mortality but instead contributed to
demand for service figures.
Urgency groups
When accepting patients on wait lists for CABG in British
Columbia, all cardiac surgeons use a common guideline
to indicate the priority for booking the operating room
according to the patient's anginal symptoms, coronary
anatomy, and left ventricular function so that surgery can
be performed within a clinically appropriate time [10]. In
this analysis, patients are classified as "urgent" if the sug-
gested time to surgery was 3 days after the treatment deci-
sion had been made, "semi-urgent" if that time was 6
weeks, or "non-urgent" if that time was 12 weeks.Journal of Cardiothoracic Surgery 2006, 1:21 http://www.cardiothoracicsurgery.org/content/1/1/21
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Demand for surgery
For each calendar week during the study period, the
demand for surgery was characterized by the size of exist-
ing wait lists and by the number of direct admissions, i.e.,
patients admitted to a hospital ward immediately after
angiography. For each patient, the wait-list size at registra-
tion was a count of patients with higher or equal urgency
to undergo CABG in the same hospital. Each patient con-
tributed 1 count to the list size for each week that he or she
remained on the wait list, except for the week of registra-
tion. Because CABG surgeries are confirmed 1 week in
advance, patients who are to undergo surgery are consid-
ered removed from the wait list during the week before
their admission date. We defined the number of direct
admissions as the weekly count of CABG surgeries per-
formed without wait-list registration.
Statistical analysis
Primary outcome
In this study, the primary outcome was the death of
patients awaiting CABG on a wait list referred to as wait-
list deaths. The time on a wait list was computed as the
number of calendar weeks from registration to surgery,
death, or wait-list removal. The date of surgeon's request
for booking the operating room serves as the date of reg-
istration on a wait list. The probability of remaining on
the list after a certain time was estimated by the product-
limit method [11]; wait-list times were treated as prospec-
tive observations that were monitored from registration to
the patient's last week on the list. The log-rank test was
used to compare the time to removal across the study
groups [12]. The average weekly rate of wait-list deaths
was determined by dividing the number of deaths by the
sum of observed wait-list times.
Study variables
The wait-list size was categorized by clearance time; i.e., a
hypothetical time within which the list could be cleared at
the maximum weekly service capacity if there were no new
arrivals [13]. We categorized wait-list size as either "1
month or less" or "more than 1 month" of clearance time.
We chose 1 month as a cut-off, reasoning that registration
on a wait list with a clearance time of 1 month or less per-
mits undergoing surgery within the planned access time of
6 weeks for semi-urgent patients. In 3 of the 4 participat-
ing hospitals, which had a service capacity of performing
15 operations per week, a wait list of 59 or fewer patients
corresponded to a clearance time of 1 month or less, and
a wait list of 60 or more patients corresponded to a clear-
ance time of more than 1 month. In the fourth hospital,
which had a service capacity of performing 25 operations
per week, a wait list of 99 or fewer patients corresponded
to a clearance time of 1 month or less, and a list of 100 or
more patients corresponded to a clearance time of more
than 1 month. The weekly number of direct admissions
was treated as a continuous variable.
Cumulative incidence for wait-list death
We used the cumulative incidence function (CIF) to char-
acterize the time-dependent, marginal probability that
pre-operative death occurs on or before a certain wait-list
week. We interpreted the cumulative incidence for wait-
list death as the proportion of patients who were to
undergo CABG but died before surgery; a number that
increased over wait-list time. The CIF for wait-list death is
defined as the integration over time of the product of the
weekly death rate and the probability of remaining on the
list [14]. The CIF of wait-list death and its standard errors
were estimated using non-parametric methods [15]. We
used a 2-sample test to compare the CIFs between catego-
ries of wait-list clearance time [16].
Regression models
The effect of wait-list clearance time on the weekly death
rate was estimated by means of discrete-time survival
regressions that yield the odds ratio (OR) as a measure of
the effect size [17]. We used discrete-time survival analysis
because wait-list time is inherently discrete and is best
measured by the number of weekly operating room sched-
ules [13]. To test for differences in the CIF between list-
size categories, we used competing-risk regression models
based on pseudo-values of the CIF [18]. The clearance-
time category was added as an indicator variable, with 1
denoting a clearance time of more than 1 month. The
exponential of the regression coefficient for that variable
gives the odds ratio of pre-operative deaths for category
"more than 1 month" relative to category "1 month or
less". Pseudo-values for the CIF for wait-list death were
computed in the presence of surgery and other competing
events at all distinct, observed event times. For each
patient, the CIF pseudo-values corresponded to a series of
binary variables equal to zero before and 1 at or after
death in the absence of censoring. The CIF models were
adjusted for subject-level correlation between pseudo-val-
ues using the generalized estimation equations. The work-
ing weight matrix was fixed and estimated as a product-
moment correlation matrix among the pseudo-values. For
the direct admissions, we interpret odds ratios as a change
in the weekly odds of wait-list death associated with 1
additional surgery performed immediately after angiogra-
phy.
Confounders
Multivariate analyses controlled for differences in
patients' characteristics and significant confounders sum-
marized in Table 1. Existing literature suggests that elderly
patients are more likely to undergo revascularization as an
urgent procedure [19]; smaller coronary vessel diameters
may account for higher risk of adverse events in womenJournal of Cardiothoracic Surgery 2006, 1:21 http://www.cardiothoracicsurgery.org/content/1/1/21
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[20]; co-existing medical conditions may delay open heart
surgery [21]; and changes in practice or supplementary
funds may reduce time to surgery [10]. We entered two
indicator variables for three comorbidity categories, refer-
ent, no co-existing conditions, and 2 comparison catego-
ries: presenting with congestive heart failure, diabetes,
chronic obstructive pulmonary disease, cancer or rheuma-
toid arthritis as suggested by Naylor and colleagues [22];
or presenting with other co-existing chronic conditions as
defined in Romano and colleagues [23].
Results
Patients
Table 1 shows the distribution of wait-listed patients and
direct admissions according to age, sex, calendar period,
urgency for surgery, comorbid conditions, and wait-list
clearance time at registration. In the group of patients who
underwent surgery without registration on wait lists, the
age distribution was similar to the listed patients, with the
majority (68%) undergoing surgery between 60 and 79
years. Compared with the listed patients, the proportion
of women (22%) was slightly higher. Differences between
these two groups by urgency and coexisting medical con-
ditions indicate that sicker patients were more likely to
undergo operation without delay. For example, less than
6% of wait-listed patients were in urgent category com-
pared with 51% for directly admitted. Similarly, almost
53% of wait-listed patients had no co-existing conditions,
compared with only 11% in the other group. Wait lists
with 1 month or less of clearance time were observed in
all urgent patients and were more prevalent in semi-
urgent than non-urgent patients (79.1% vs 44.7%, respec-
tively).
Outcomes of registration for CABG
By 52 weeks on the list, 7724 (86.1%) patients had under-
gone surgery, and 767 (8.6%) had been removed without
surgery for various reasons such as having died while
awaiting surgery (92 patients), continuing medical treat-
ment (176), refusal of surgery (188), having been
accepted for surgery by another surgeon or hospital (99),
having undergone another type of surgery (23), or other
reasons (189). Death certificates were available for 87 of
the 92 patients who died while awaiting operation, and 5
sudden deaths were reported by the participating hospi-
tals. Of the 515 urgent patients, 98 (19.0%) were down-
Table 1: Characteristics of 8,966 wait-listed patients and 10,467 directly admitted patients isolated coronary artery bypass surgery in 
British Columbia 1991–2001
Characteristic Wait-Listed patients N(%) Direct admissions N(%)
Age group (yr)
<50 yr 717 (8.0) 808 (7.7)
50–59 yr 1966 (21.9) 2082 (19.9)
60–69 yr 3425 (38.2) 3689 (35.2)
70–79 yr 2676 (29.8) 3509 (33.5)
≥80 yr 182 (2.0) 379 (3.6)
Sex
Women 1581 (17.6) 2313 (22.1)
Men 7385 (82.4) 8154 (77.9)
Period of registration/surgery
1991–1992 1675 (18.7) 1770 (16.9)
1993–1994 1859 (20.7) 1526 (14.6)
1995–1996 1867 (20.8) 1686 (16.1)
1997–1998 1853 (20.7) 1997 (19.1)
1999–2000 1712 (19.1) 2454 (23.4)
2001 1034 (9.9)
Urgency at registration/surgery
Urgent 515 (5.7) 5353 (51.1)
Semi-urgent 6444 (71.9) 4536 (43.3)
Non-urgent 2007 (22.4) 523 (5.0)
Not provided 55 (0.5)
Comorbidity at registration/surgery
Major conditions† 1930 (21.5) 4040 (38.6)
Other conditions‡ 2304 (25.7) 5268 (50.3)
None 4732 (52.8) 1159 (11.1)
Wait-list clearance time
1 month or less 6512 (72.6)
more than 1 month 2454 (27.4)
†congestive heart failure, diabetes, chronic obstructive pulmonary disease, rheumatoid arthritis, cancer
‡peripheral vascular disease, cerebrovascular disease, dementia, peptic ulcer disease, hemiplegia, renal disease, or liver diseaseJournal of Cardiothoracic Surgery 2006, 1:21 http://www.cardiothoracicsurgery.org/content/1/1/21
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graded to the semi-urgent or non-urgent category at the
time of surgery.
More than 10% (258) of non-urgent patients and about
5% (212) of semi-urgent patients were still on the wait
lists at 52 weeks. Five patients in the urgent group had cal-
culated wait times of more than 52 weeks. One of those
patients was eventually removed by request, the urgency
for surgery was downgraded in 2 patients, and the reason
for the delay in surgery was unknown in 2 patients. In
total, 254 (2.8%) patients were removed from the wait
lists for CABG after being deemed unfit for surgery.
Figure 1 shows the estimated probability of remaining on
the list by week since registration and wait-list clearance
time. Lists with longer clearance times were associated
with longer wait times (the log-rank test = 266.4, df = 1, p
< 0.001). When a clearance time was 1 month or less,
75%, 50%, and 25% of patients remained on wait lists
after 4, 9, and 18 weeks, respectively. For a clearance time
Estimated probability of remaining on a coronary-artery bypass grafting wait list by the number of weeks since registration and  wait-list clearance times in semi-urgent and non-urgent groups combined Figure 1
Estimated probability of remaining on a coronary-artery bypass grafting wait list by the number of weeks since registration and 
wait-list clearance times in semi-urgent and non-urgent groups combined.
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of more than 1 month, 75%, 50%, and 25% of patients
remained on the list after 6, 14, and 29 weeks, respec-
tively.
Death rates by clearance time
The effect of wait-list clearance time was studied in semi-
urgent and non-urgent patients because all urgent patients
fell in one clearance time category. There were 49 wait-list
deaths over 84,710 patient-weeks of follow-up in category
"1 month or less", and 39 deaths over 49,219 patient-
weeks in category "more than 1 month". The observed
average death rate was higher in category "more than 1
month" than in category "1 month or less", 0.79 (95%
confidence interval [CI] 0.54–1.04) vs. 0.58 (95% CI
0.42–0.74) per 1000 patient-weeks. After adjustment for
age, sex, urgency for surgery, calendar period, co-existing
conditions, and weeks on the list, the weekly odds of wait-
list death were 1.6 higher greater for a longer clearance
time, the adjusted OR = 1.60 (95% CI 1.01–2.53). In
semi-urgent and non-urgent groups, the product of the
Estimated cumulative incidence for death on the wait list by the number of weeks since registration and urgency group, thin  lines represent standard errors for the cumulative incidence estimate for each week. Figure 2
Estimated cumulative incidence for death on the wait list by the number of weeks since registration and urgency group, thin 
lines represent standard errors for the cumulative incidence estimate for each week
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average death rates and weeks on the wait list served as a
good approximation for the cumulative hazards, suggest-
ing that the hazard functions for wait-list death were con-
stant over wait-list time.
Cumulative incidence for wait-list death
Figure 2 shows the estimated cumulative incidence for
wait-list death by clearance-time categories in semi-urgent
and non-urgent patients combined. The observed (unad-
justed) proportion of wait-list deaths by 52 weeks was
lower in category "1 month or less" than in category
"more than 1 month" (0.8% [49 deaths] vs. 1.6% [39
deaths], Gray's 2-sample test = 10.1, df = 1, P < 0.005).
Higher weekly death rates and longer waits in the group
with a clearance time of more than 1 month contributed
to the differences in the cumulative incidence of wait-list
death between the groups studied. After adjustment for
age, sex, urgency for surgery, calendar period, co-existing
conditions, and weeks on the list, the effect of wait-list
size at registration remained significant. The odds of wait-
list death were 64% higher in patients on a list with a
clearance time of more than 1 month than in those on a
list with a clearance time of 1 month or less, the adjusted
OR = 1.64 (95%CI, 1.02–2.63), Table 2. As expected, the
urgency for surgery had a major influence on the cumula-
tive incidence of wait-list death as well. Non-urgent
patients had a higher cumulative incidence of pre-opera-
tive death than did semi-urgent patients for almost all
weeks on the list (Gray's 2-sample test = 9.3, df = 1, P
<0.001). After controlling for confounders, the difference
between urgency groups remained significant and inde-
pendent from the list-size effect, the adjusted OR = 1.69
(95%CI, 1.05–2.74). Direct admissions did not alter the
odds of death for semi-urgent and non-urgent patients.
Discussion
We examined the relationship between the length of the
wait list at the time of registration for CABG and the risk
of death before surgery in patients awaiting that operation
on any of multiple wait lists in a health system in which
all medically necessary services are publicly funded. Using
records from the provincial population-based registry of
patients identified as needing surgical revascularization,
we compared the cumulative incidence for wait-list death
between the two categories of wait-list size according to a
clearance time. The list size was a simple count of patients
with higher or equal surgical priority who were on a wait
list at the time of registration of a new patient. Out of 88
wait-list deaths that occurred in the two less urgent
groups, 44 deaths in semi-urgent and 15 deaths in non-
urgent groups were related to cardiovascular disease. We
report on all-cause mortality because the accuracy of
death certificate codes is a concern in this analysis; using
all-cause mortality could not have induced bias in the
results [24].
Our results show that wait-list size is associated with the
probability that a semi-urgent or non-urgent patient
would die before surgery by a certain wait-list week. The
patients registered on a list with a clearance time of more
than 1 month had 60% higher weekly death rate after
adjustment than those on a list with a clearance time of 1
month or less. Longer wait times (p < 0.001) and a higher
death rate contributed to a higher cumulative incidence
for wait-list death in the patients registered on a list with
a clearance time of more than 1 month, the adjusted OR
= 1.64 (95% CI 1.02–2.63). The number of patients who
underwent CABG without having been registered on a
wait list in the same hospital exerted no independent
effect.
Other investigators concerned with delay in treatment for
patients who require a CABG have reported on the impact
of patient prioritization [25,26], risks of delayed treat-
ment [1,2,27], and the worsening symptoms and morbid-
ity associated with a long wait for surgery [3,28]. In
quantifying the risk of adverse events on wait lists for
CABG surgery, the Kaplan-Meier method is often used to
estimate the cumulative probability of the occurrence of
an event by certain time after registration for surgery
[3,28,29]. It has been found, however, that the comple-
ment of Kaplan-Meier estimator overestimates the pro-
portion of the event in the competing risks setting [30].
Because patients on a wait list are subject to competing
events such as surgery, death, or removal from the wait list
for other reasons, the Kaplan-Meier method produces
probability estimates that are only valid in a hypothetical
situation in which all competing risks are removed before
Table 2: Association between urgency, wait-list clearance times and cumulative incidence for death on the wait list as measured by 
odds ratios derived from discrete-time survival regression models
Effect Unadjusted OR(95% CI) Adjusted OR*(95% CI)
non-urgent vs semi-urgent 1.61(1.00, 2.59) 1.69(1.05, 2.74)
clearance time of 1 month or less 1.00 1.00
clearance time of more than 1 month 1.67(1.05, 2.66) 1.64(1.02, 2.63)
direct admission† -- 1.00(1.00, 1.00)
*Adjusted for age, sex, comorbidity, calendar period, and week on the list
†Associated with one additional surgery performed without wait-list registrationJournal of Cardiothoracic Surgery 2006, 1:21 http://www.cardiothoracicsurgery.org/content/1/1/21
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the patient's death without altering the risk of death [31].
Without the assumption of independent competing
events, the Kaplan-Meier method is not valid and should
not be used [32]. However, the independence of wait out-
comes cannot be verified from data and may not be real-
istic, because the low proportion of wait-list deaths may
indicate either a low risk of death or a high rate of surgery.
Appropriate statistical instruments include the CIF that
can be estimated without the independence assumption
for competing events. The CIF describes the time-depend-
ent marginal probability that pre-operative death occurs
on or before a certain time of registration on a wait list
after the probability of surviving multiple competing
events has been considered [14,33,34]. Pepe and Mori
argued that the CIF is a more accurate and comprehensive
summary of the risk of death in a competing-risks setting
than are death rates or cumulative hazards, which cannot
be translated to the probability of death [15].
Estimated cumulative incidence for death on the wait list by the number of weeks since registration and wait-list clearance  times in semi-urgent and non-urgent groups combined, thin lines represent standard errors for the cumulative incidence esti- mate for each week Figure 3
Estimated cumulative incidence for death on the wait list by the number of weeks since registration and wait-list clearance 
times in semi-urgent and non-urgent groups combined, thin lines represent standard errors for the cumulative incidence esti-
mate for each week
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Misclassification of the recorded urgency for treatment is
a concern in this analysis. Retrieved from the registry, the
urgency category is a composite variable that is based on
a variety of clinical factors. No audit was performed to
evaluate the quality of those records. The observation that
higher priority patients were more likely to undergo
CABG via direct admission indicates that the degree of
misclassification of priority was likely small. Another con-
cern is that in some patients, the urgency for surgery was
reclassified at the time of surgery. However, the timing of
changes in urgency was not recorded.
Conclusion
The contribution of this paper is two-fold. First, the cumu-
lative incidence for wait-list death in relation to wait-list
size at the time of registration for CABG, to our knowl-
edge, has not been reported previously. We found that
long wait lists are associated with increased probability
that a patient dies before surgery after accounting for the
surgery rate in semi-urgent and non-urgent patients. Sec-
ond, physicians who advise patients to undergo revascu-
larization with a cardiac surgeon can use our results to
consider the risk of pre-surgical death that is associated
with the current length of wait list of the surgeon.
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